JDD Highlights

The Latest Research & Discoveries in Psoriasis, Anti-Aging, Aesthetics, and Medical Dermatology

By August 5, 2020No Comments

Dermatology News

JDD Highlights

The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.

Read the JDD Now

Psoriasis, Public Health, Anti-Aging, Aesthetic, and Medical Dermatology

The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on  psoriasis with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.

Article Highlights

Editor's Picks

You May Also Like

AcneFeatured ArticlesLatest NewsThe Latest
September 25, 2025

From the Vault: Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris

Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Journal of Drugs in Dermatology JDD Article About Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic AlopeciaAlopeciaFeatured ArticlesLatest NewsThe Latest
September 24, 2025

Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia

Small Channels, Smarter Delivery -  A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
Journal of Drugs in Dermatology JDD Article About The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart ReviewAtopic DermatitisFeatured ArticlesLatest NewsThe Latest
September 24, 2025

The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review

Dupilumab in Diverse Skin — Are Adverse Events Really the Same? Atopic dermatitis isn’t one-size-fits-all: chronic type 2 inflammation, barrier dysfunction, and S. aureus colonization are core features, but presentation…

Leave a Reply